Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/105820
Title: Combining Virtual Screening Protocol and In Vitro Evaluation towards the Discovery of BACE1 Inhibitors
Authors: Coimbra, Judite R. M. 
Baptista, Salete 
Dinis, Teresa 
Silva, Maria M. C. 
Moreira, Paula I. 
Santos, Armanda Emanuela Castro e 
Salvador, Jorge A. R. 
Keywords: Alzheimer’s disease (AD); amyloid- (A ); BACE1; small bioactive molecules; virtual screening; pharmacophore modelling; molecular docking; structure- and ligand-based methods
Issue Date: 1-Apr-2020
Publisher: MDPI
Project: CENTRO-01-0247-FEDER-003269 (Drugs2CAD) 
CENTRO-01-0145-FEDER-000012 (HealthyAging2020) 
UIDB/04539/2020 
RECI/QEQ-QFI/0168/2012 
CENTRO-07-CT62-FEDER-002012 
UID/QUI/00313/2019 
SFRH/BD/138460/2018 
University of Coimbra 
Serial title, monograph or event: Biomolecules
Volume: 10
Issue: 4
Abstract: The treatment options for a patient diagnosed with Alzheimer's disease (AD) are currently limited. The cerebral accumulation of amyloid-β (Aβ) is a critical molecular event in the pathogenesis of AD. When the amyloidogenic β-secretase (BACE1) is inhibited, the production of Aβ peptide is reduced. Henceforth, the main goal of this study is the discovery of new small bioactive molecules that potentially reach the brain and inhibit BACE1. The work was conducted by a customized molecular modelling protocol, including pharmacophore-based and molecular docking-based virtual screening (VS). Structure-based (SB) and ligand-based (LB) pharmacophore models were designed to accurately screen several drug-like compound databases. The retrieved hits were subjected to molecular docking and in silico filtered to predict their ability to cross the blood-brain barrier (BBB). Additionally, 34 high-scoring compounds structurally distinct from known BACE1 inhibitors were selected for in vitro screening assay, which resulted in 13 novel hit-compounds for this relevant therapeutic target. This study disclosed new BACE1 inhibitors, proving the utility of combining computational and in vitro approaches for effectively predicting anti-BACE1 agents in the early drug discovery process.
URI: https://hdl.handle.net/10316/105820
ISSN: 2218-273X
DOI: 10.3390/biom10040535
Rights: openAccess
Appears in Collections:FFUC- Artigos em Revistas Internacionais
I&D CIBB - Artigos em Revistas Internacionais
I&D ICBR - Artigos em Revistas Internacionais

Files in This Item:
File Description SizeFormat
biomolecules-10-00535-v2.pdf7.48 MBAdobe PDFView/Open
Show full item record

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons